Current Health’s AI-Powered Remote Patient Monitoring Device Gets FDA Clearance

Current AI wearable

An AI-powered wearable for remote patient monitoring has received Class II clearance from the FDA for hospital care. The wearable device, developed by Edinburgh, Scotland-based Current Health, continuously and automatically monitors patients to help better determine health trajectory and allows clinicians to intervene earlier.

Related Qardio Launches Remote Patient Monitoring While Increasing Revenue Opportunities

Healthcare providers in the U.S. and U.K. are deploying Current to change their patient delivery models from reactive to proactive care to produce better patient outcomes. Current’s approach will help health organizations reduce unnecessary hospital readmissions for patients whose conditions deteriorate after treatment — an expensive and cumbersome clinical burden that costs U.S. hospitals more than $40 billion annually, says a press release.

“The Mount Sinai Health System works with innovative and leading-edge companies like Current to support our commitment to providing world-class patient care. Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier,” said Dr. Scott Lorin, president of Mount Sinai Brooklyn.

Current has the largest real-time physiological data set, making it the most accurate, all-in-one wireless wearable currently approved for use in the EU and U.S. The company’s proprietary algorithms continuously analyze data, along with relevant contextual patient information, to offer actionable and proactive insights into the wearer’s health. It seamlessly integrates with third-party devices to capture additional metrics, building patient-specific digital therapeutics and recommendations.

Wearable device for remote patient monitoring

In the UK, Current is being used by Dartford and Gravesham NHS Trust, which serves a local population of 500,000 people. These two hospitals use Current to remotely monitor patients after discharge. The Current use resulted in a 22% reduction in home visits and fewer hospital readmissions and emergency department visits, which freed up skilled nursing time and helped patients feel safe and secure.

Related Cambridge Consultants Develops Verum – an AI-Powered Remote Patient Monitoring Platform

“At Current, we’re a small team of individuals committed to changing the world through proactive healthcare,” said Christopher McCann, CEO of Current. “Our team worked hard to get here, and it’s just the first step toward monitoring the health of every human being to identify sickness earlier with the goal of saving lives. Today, we’re in the hospital, tomorrow the home, and in the near future, we’ll be everywhere. We are just getting started.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, Viewpointsystem and many more. Register now to be part of #WTUS19

Previous articleGatorade’s GX Sweat Patch Helps Athletes Keep Track of Hydration and Lost Nutrients
Next articleOracle mHealth Platform is Revolutionizing Clinical Trials with Remote Monitoring Devices
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)